Pharma Omnichannel · HCP engagement · AI-enabled engagement
Omnichannel strategy that field, medical and marketing teams can run, and leaders can measure.
I help Commercial, Medical and Digital leaders in pharma design customer engagement journeys, Next Best Action logic and measurement frameworks that work in real delivery environments.
The argument
Pharma has invested heavily in AI, yet most companies cannot show the commercial return. The constraint is the operating model around the technology.
From The Omnichannel Operating Model (2026)
Omnichannel Maturity Self-Check
How ready is your organization for the next stage of engagement?
Ten questions, about four minutes. See your maturity level across six dimensions and the two areas to address first.
About
Twenty years inside global pharma, now building a global advisory practice
Osman Daggezen is the founder of OD Pharma Consulting and the author of three books on pharma Omnichannel. A former Global Vice President at Viatris and senior leader at Pfizer, he helps Commercial, Medical and Digital teams turn Omnichannel strategy into measurable HCP engagement, and frequently moderates industry webinars on pharma Omnichannel.
I spent more than fifteen years at Pfizer in customer experience and business technology leadership, then built and led Omnichannel Enablement and Marketing Operations globally at Viatris. Since 2022 I have run OD Pharma Consulting, working with multinational pharma companies across the US, Europe, the Gulf, LATAM and Turkey, and I regularly moderate industry webinars on pharma Omnichannel.
How I work
From an honest baseline to measured impact
Every program moves through four practical steps, each with a clear output. The detailed models behind each step are shared in client work.
Diagnose
Where the organization stands today
Design
Customer engagement journeys and the operating model
Activate
Capability, content and orchestration in the field
Measure
Progress tracked against business outcomes
Focus areas
What I write, speak and advise on
Twenty years inside global pharma organizations showed me that engagement programs succeed or fail on execution detail.
Decision-led engagement
Engagement planned around the stages of an HCP treatment decision, with each channel and piece of content given a clear role at each stage.
AI-enabled engagement and Next Best Action
Signals, data foundations and orchestration logic that make Next Best Action useful to representatives, medical teams and marketers in daily work.
Omnichannel capability building
Practical training, workshop masterkits and train-the-trainer programs that change how cross-functional teams plan and run customer engagement journeys.
Measurement, impact and ROI
KPI frameworks that connect activity, cost and engagement quality to business outcomes, so leadership teams can decide where to invest next.
Start here
Find what is relevant to your role
The site serves colleagues across pharma and life sciences functions. Each path leads to the material most useful for that role.
Commercial and Marketing leaders
Decision-led engagement, journey design, content-to-journey mapping and brand-level Omnichannel planning.
ViewMedical Affairs
Scientific engagement models, insight capture and AI-supported learning for Medical teams.
ViewSales and field leadership
Practical field force training that positions Omnichannel as an engagement tool for representatives and managers.
ViewDigital, data and technology
Next Best Action prerequisites, signal design, orchestration logic and platform choices.
ViewHR, L&D and Training
Capability building programs, workshop masterkits and train-the-trainer delivery across markets.
ViewProcurement
Engagement formats, workshop options and the contracting route through OD Pharma Consulting.
ViewExecutive leadership
Maturity assessment, investment priorities and the measurement logic that links engagement to business outcomes.
ViewIn the room
Keynotes, talks and workshops
I speak at industry events, frequently moderate webinars on pharma Omnichannel, and run hands-on workshops with Commercial, Medical and Digital teams across markets.
Named in Top 12 Marketing & Omnichannel experts to follow in 2025, Medical.Watch.
Books
Pharma Omnichannel & AI Engagement Strategy Series
Three practical books for Marketing, Sales, Medical Affairs, Training and Digital teams, available on Amazon in paperback, hardcover and Kindle editions.
The Omnichannel Operating ModelNew
Pharma has invested heavily in AI, yet most companies cannot show the commercial return. The constraint is the operating model around the technology. This practitioner blueprint sets out the redesign, with cross-functional pods that own customer decisions, governance that moves at their pace, measurement built on decision progression, and an 18 to 36 month roadmap for where to start.
Omnichannel to Optichannel Transformation in Pharma
Omnichannel Customer Engagement in Pharma
On LinkedIn
New thinking is published on LinkedIn first
Two to three posts a month, plus longer articles, drawn from client work, workshops and industry events. Topics include Omnichannel, operating models, Next Best Action and AI-enabled engagement.
Insights
Recent writing
Articles with industry media and partners, and essays from the archive.
- Accelerating the medical wheel with AI. From engagement to impact (co-authored with Gregg Fisher, The Stem)pharmaphorum · March 2026
- How Medical Teams Can Use Social Data to Enhance Omnichannel StrategyMedical.Watch · May 2025
- Navigating Veeva Vault and Salesforce Life Sciences Cloud. Best CRM practices for CIOs (contributor)Indegene · July 2025
Can AI Improve the Medical, Legal and Regulatory (MLR) Process?
AI-supported first reviews could shorten one of the slowest steps in pharma content delivery.
HCP Engagement in Pharma: Channel Trends
Delivery matters as much as content. Four basics for reaching HCPs through the channels they prefer.
HCP Engagement in Pharma: Content Trends
Five content principles for moving from product-based to value-based HCP engagement.
Questions and answers
Questions people ask about pharma Omnichannel
Short, direct answers drawn from the books and client work.
What is Omnichannel in pharma?
Omnichannel in pharma is the coordinated planning of HCP and patient engagement across field, digital, medical and service channels around one view of the customer. Each channel plays a defined role in a customer engagement journey, and the journey is measured by the customer's progress through it.
What is the difference between Omnichannel and Optichannel?
Optichannel is the next step after Omnichannel, in which engagement is optimized for each individual customer. Omnichannel connects channels around the customer. Optichannel then selects the best next interaction for that customer using data, AI and decision-stage logic, which Osman Daggezen describes in Omnichannel to Optichannel Transformation in Pharma (2025).
What is an Omnichannel operating model in pharma?
An Omnichannel operating model is the structure of teams, roles, governance, technology and measurement that lets a pharma company run customer engagement at the pace its customers require. In The Omnichannel Operating Model (2026), Osman Daggezen argues that the operating model around the technology determines whether AI investment produces commercial return.
Why do pharma AI and Omnichannel investments often fail to show return?
Pharma AI and Omnichannel investments often fail to show return because they are placed inside operating models built for annual brand plans and sequential review cycles. Cross-functional pods that own customer decisions, faster governance and measurement based on decision progression are the changes that most often unlock return.
Advisory
Planning an Omnichannel, NBA or capability program?
Through OD Pharma Consulting I support pharma teams with Omnichannel maturity assessments, customer engagement journey design, capability building, Next Best Action planning and impact measurement.